Last reviewed · How we verify
OPV plus BCG
At a glance
| Generic name | OPV plus BCG |
|---|---|
| Sponsor | Bandim Health Project |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Sex-Differential Health Interventions In Low-Birth-Weight Infants (NA)
- Mobile Nudges to Increase Early Vaccination Coverage in Rural Areas (NA)
- Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OPV plus BCG CI brief — competitive landscape report
- OPV plus BCG updates RSS · CI watch RSS
- Bandim Health Project portfolio CI